Evaluating Cardiovascular Phenotypes Using Induced Pluripotent Stem Cells

Part of paid clinical trials in La Jolla, California.

Sponsor
Scripps Translational Science Institute
Study ID
NCT01517425
Status
Enrolling By Invitation

Conditions

  • Coronary Artery Disease

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

This research is being done to understand how changes in DNA may put people at risk for developing coronary artery disease. Stem cells will be made using cells from blood and/or skin biopsy samples. We are trying to understand which specific changes in DNA negatively impact a person's health.

Key Dates

Start date
Nov 30, 2012
Status verified
Jan 2025
Primary completion
Jul 31, 2025
Completion
Jul 31, 2030

Study Design

Enrollment
200 participants (estimated)

Arms

  • Arm: Cases
    Subjects previously enrolled in the Scripps Genebank Study
  • Arm: Controls
    Subjects previously enrolled in the Scripps Healthy Elderly Active Longevity (HEAL) Cohort

Primary Outcome Measure

iPSC development [ Time Frame: five years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Scripps Translational Science InstituteLa JollaCalifornia92037-

Find similar trials in La Jolla, CA

By research site
Scripps Translational Science Institute· La Jolla, CA

Related Studies